参考文献/References:
[1]毛伟成,蓝荣伟,蒙南新,等.狂犬病流行与防治研究进展[J].医学动物防制,2015,31(3):283-286. [2]舒振林,肖小强.狂犬病并发心血管系统表现的临床分析[J].医学信息,2011,24(6):2656-2657. [3]陈素梅,林琪.10例不同首发症状的狂犬病病例分析[J].当代医学,2011,17(8):89-90. [4]赵晓慧.以尿失禁为首发症状的狂犬病一例[J].中华传染病杂志,2015(6):370-370. [5]姚永秀,李桓,姚利群.狂犬病患者发病特点及防控措施分析[J].检验医学与临床,2014,11(3):388,390.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(19):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(19):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(19):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]达 珍,次 旦,罗央措,等.西藏仲巴县1例人狂犬病的流行病学调查[J].医学信息,2018,31(07):190.[doi:10.3969/j.issn.1006-1959.2018.07.069]
DA Zhen,CI Dan,LUO Yang-cuo,et al.Epidemiological Survey of 1 Cases of Human Rabies in Zhongba County of Tibet[J].Medical Information,2018,31(19):190.[doi:10.3969/j.issn.1006-1959.2018.07.069]
[6]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(19):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[7]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Medical Information,2022,35(19):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[8]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(19):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[9]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[10]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(19):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]